PH BAPTIST EASLEY HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1.2M
- Transactions
- 160
- Companies
- 25
- Average per transaction
- $7,568
Who reported the payments
| Endotronix, Inc. | $703,281 |
| AstraZeneca | $118,861 |
| Pramand LLC | $91,500 |
| Philips North America LLC | $34,422 |
| Smith+Nephew | $32,222 |
| Astrazeneca UK Limited | $30,485 |
| AbbVie | $30,443 |
| ZOLL Circulation Inc | $27,800 |
| Novartis | $22,461 |
| Rejoni Inc. | $20,350 |
| QOL Medical, LLC | $19,019 |
| Contego Medical, Inc | $15,135 |
| Instylla, Inc. | $10,650 |
| Abbott | $10,360 |
| Stryker | $9,534 |
| Novo Nordisk AS | $7,440 |
| Boston Scientific | $7,085 |
| Angiodynamics, Inc. | $6,583 |
| Cook Medical LLC | $4,601 |
| Siemens Medical Solutions USA, Inc. | $2,500 |
| Medical Device Business Services, Inc. | $2,000 |
| Acerta Pharma LLC | $1,842 |
| ZOLL Medical Corporation | $1,000 |
| Beigene, Ltd. | $1,000 |
| Janssen Research & Development, LLC | $311 |